Inhibitors Of Serine Protease Activity And Their Use In Methods And Compositions For Treatment Of Graft Rejection And Promotion Of Graft Survival

Patent No. EP1909810 (titled "Inhibitors Of Serine Protease Activity And Their Use In Methods And Compositions For Treatment Of Graft Rejection And Promotion Of Graft Survival") was filed by The Board OF Regents OF The University OF Colorado on Jun 7, 2006. The application was issued on Aug 23, 2017.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BALEMAJun 17, 2015STRAUS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1909810

THE BOARD OF REGENTS OF THE UNIVERSITY OF COLORADO
Application Number
EP06772664A
Filing Date
Jun 7, 2006
Status
Patent Maintained As Amended
Jul 21, 2017
Publication Date
Aug 23, 2017